Financials
- Market Capitalization 28.52 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
21.71
売上高対価格比率
9.17
1株当たり配当金
0.88
配当利回り(%)
2.28
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 209.31 USD | -0.74% | +0.57% | +7.84% | +277.82% | 44.86 B USD | ||
| 412 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 263.66 USD | -0.32% | +11.96% | +18.91% | -41.85% | 35.28 B USD | ||
| 482 | INSM Insmed Incorporated - Common Stock | 125.77 USD | -0.72% | +6.39% | +26.84% | -22.39% | 27.47 B USD | ||
| 502 | INCY Incyte Corporation - Common Stock | 127.85 USD | -0.12% | +2.73% | +3.11% | +48.30% | 25.91 B USD |